Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues.

PubWeight™: 1.67‹?› | Rank: Top 3%

🔗 View Article (PMID 8275091)

Published in Nat Genet on November 01, 1993

Authors

T V Strong1, D A Tagle, J M Valdes, L W Elmer, K Boehm, M Swaroop, K W Kaatz, F S Collins, R L Albin

Author Affiliations

1: Department of Internal Medicine, University of Michigan, Ann Arbor 48109.

Articles citing this

The corticostriatal pathway in Huntington's disease. Prog Neurobiol (2006) 1.99

Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc Natl Acad Sci U S A (1999) 1.84

Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice. Proc Natl Acad Sci U S A (2000) 1.66

Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function. Neuroscience (2011) 1.62

Transcription-induced CAG repeat contraction in human cells is mediated in part by transcription-coupled nucleotide excision repair. Mol Cell Biol (2007) 1.61

Poly-L-glutamine forms cation channels: relevance to the pathogenesis of the polyglutamine diseases. Biophys J (2000) 1.53

Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc Natl Acad Sci U S A (1995) 1.50

Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity. Proc Natl Acad Sci U S A (2002) 1.46

Molecular and clinical correlations in spinocerebellar ataxia type I: evidence for familial effects on the age at onset. Am J Hum Genet (1994) 1.38

Cardiac dysfunction in the R6/2 mouse model of Huntington's disease. Neurobiol Dis (2006) 1.31

Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc Natl Acad Sci U S A (1999) 1.30

Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease. Proc Natl Acad Sci U S A (2009) 1.17

A cellular perspective on conformational disease: the role of genetic background and proteostasis networks. Curr Opin Struct Biol (2010) 1.13

Three Huntington's Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes. PLoS One (2015) 1.12

Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat. Mol Med (1995) 1.11

Somatic mosaicism of expanded CAG repeats in brains of patients with dentatorubral-pallidoluysian atrophy: cellular population-dependent dynamics of mitotic instability. Am J Hum Genet (1996) 1.10

Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease. Neuroscience (2008) 1.08

Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease. Neuroscientist (2011) 1.08

Dysfunction of the CNS-heart axis in mouse models of Huntington's disease. PLoS Genet (2014) 1.07

Role of inositol 1,4,5-trisphosphate receptors in pathogenesis of Huntington's disease and spinocerebellar ataxias. Neurochem Res (2011) 1.04

Neurodegenerative processes in Huntington's disease. Cell Death Dis (2011) 1.03

An upstream open reading frame impedes translation of the huntingtin gene. Nucleic Acids Res (2002) 1.03

Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc Natl Acad Sci U S A (1996) 1.03

Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease. Philos Trans R Soc Lond B Biol Sci (1999) 1.03

Transcription elongation and tissue-specific somatic CAG instability. PLoS Genet (2012) 1.01

High-resolution physical and transcript map of human chromosome 2p21 containing the sitosterolaemia locus. Eur J Hum Genet (2001) 1.01

Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body. Histol Histopathol (2008) 0.99

The ubiquitin-proteasome pathway in Huntington's disease. ScientificWorldJournal (2008) 0.99

Genetics and neuropathology of Huntington's disease. Int Rev Neurobiol (2011) 0.99

Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptor. Proc Natl Acad Sci U S A (2000) 0.96

Skeletal muscle pathology in Huntington's disease. Front Physiol (2014) 0.94

Abnormal morphology of peripheral cell tissues from patients with Huntington disease. J Neural Transm (Vienna) (2009) 0.94

Intrajugular vein delivery of AAV9-RNAi prevents neuropathological changes and weight loss in Huntington's disease mice. Mol Ther (2014) 0.92

Molecular cloning of a full-length cDNA for dentatorubral-pallidoluysian atrophy and regional expressions of the expanded alleles in the CNS. Am J Hum Genet (1995) 0.91

HDAC4-myogenin axis as an important marker of HD-related skeletal muscle atrophy. PLoS Genet (2015) 0.91

The biological function of the Huntingtin protein and its relevance to Huntington's Disease pathology. Curr Trends Neurol (2011) 0.90

CAG trinucleotide RNA repeats interact with RNA-binding proteins. Am J Hum Genet (1996) 0.90

Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium. Future Neurol (2010) 0.89

Tissue-specific somatic mosaicism in spinal and bulbar muscular atrophy is dependent on CAG-repeat length and androgen receptor--gene expression level. Am J Hum Genet (1999) 0.88

The Huntington's disease-related cardiomyopathy prevents a hypertrophic response in the R6/2 mouse model. PLoS One (2014) 0.87

Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases. Front Genet (2014) 0.86

Expression and protein-binding studies of the EEN gene family, new interacting partners for dynamin, synaptojanin and huntingtin proteins. Biochem J (2000) 0.85

Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells. BMC Biochem (2013) 0.82

Altered Ca(2+) signaling in skeletal muscle fibers of the R6/2 mouse, a model of Huntington's disease. J Gen Physiol (2014) 0.80

Mitochondrial functional alterations in relation to pathophysiology of Huntington's disease. J Bioenerg Biomembr (2010) 0.80

Human induced pluripotent stem cells for monogenic disease modelling and therapy. World J Stem Cells (2016) 0.80

Therapeutic approaches to delay the onset of Alzheimer's disease. J Aging Res (2011) 0.79

A review of creatine supplementation in age-related diseases: more than a supplement for athletes. F1000Res (2014) 0.79

Obsessive-Compulsive Disorder Symptoms in Huntington's Disease: A Case Report. Rev Colomb Psiquiatr (2008) 0.79

Huntington's disease is a multi-system disorder. Rare Dis (2015) 0.78

Real-time imaging of Huntingtin aggregates diverting target search and gene transcription. Elife (2016) 0.78

Impaired Nitric Oxide Mediated Vasodilation In The Peripheral Circulation In The R6/2 Mouse Model Of Huntington's Disease. Sci Rep (2016) 0.78

Islet beta-cell area and hormone expression are unaltered in Huntington's disease. Histochem Cell Biol (2008) 0.77

Huntington disease: advances in molecular and cell biology. J Inherit Metab Dis (1997) 0.77

Inositol 1,4,5-tripshosphate receptor, calcium signaling, and polyglutamine expansion disorders. Curr Top Membr (2010) 0.75

Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt(Q111/+) model of Huntington's disease. Sci Rep (2017) 0.75

Evidence for dynamic and multiple roles for huntingtin in Ciona intestinalis. Invert Neurosci (2013) 0.75

Neurogenetics: now and the future. Trans Am Clin Climatol Assoc (1995) 0.75

Oral treatment with herbal formula B307 alleviates cardiac failure in aging R6/2 mice with Huntington's disease via suppressing oxidative stress, inflammation, and apoptosis. Clin Interv Aging (2015) 0.75

Fast-to-Slow Transition of Skeletal Muscle Contractile Function and Corresponding Changes in Myosin Heavy and Light Chain Formation in the R6/2 Mouse Model of Huntington's Disease. PLoS One (2016) 0.75

Of mice and men: solving the molecular mysteries of Huntington's disease. J Anat (2000) 0.75

Huntington's disease and mitochondrial alterations: emphasis on experimental models. J Bioenerg Biomembr (2010) 0.75

Articles by these authors

A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (1995) 15.20

The functional anatomy of basal ganglia disorders. Trends Neurosci (1989) 12.28

Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res (1991) 9.56

Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (1997) 7.95

Directional cloning of DNA fragments at a large distance from an initial probe: a circularization method. Proc Natl Acad Sci U S A (1984) 7.38

The mammalian gene collection. Science (1999) 7.19

Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science (1997) 6.66

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet (1995) 5.83

Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet (1997) 5.58

The molecular genetics of human hemoglobin. Prog Nucleic Acid Res Mol Biol (1984) 5.50

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science (1996) 5.06

Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nat Genet (1999) 4.79

Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci U S A (1990) 4.74

Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med (1990) 4.60

Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science (1997) 4.55

Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature (1992) 4.42

Direct sequencing of enzymatically amplified human genomic DNA. Proc Natl Acad Sci U S A (1988) 4.41

TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1. Cell (1995) 4.34

Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nat Genet (1996) 4.19

Genetic discrimination and health insurance: an urgent need for reform. Science (1995) 4.08

Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science (1993) 3.88

Construction of a general human chromosome jumping library, with application to cystic fibrosis. Science (1987) 3.87

Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum Mol Genet (2001) 3.84

Characterization of the CHD family of proteins. Proc Natl Acad Sci U S A (1997) 3.76

Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell (1990) 3.70

Phylogenetic footprinting reveals a nuclear protein which binds to silencer sequences in the human gamma and epsilon globin genes. Mol Cell Biol (1992) 3.57

The cost-utility of screening for depression in primary care. Ann Intern Med (2001) 3.38

A de novo Alu insertion results in neurofibromatosis type 1. Nature (1991) 3.29

Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell (1999) 3.16

Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. Science (1991) 3.12

The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet (1995) 3.05

The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med (1995) 2.88

Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A (1988) 2.78

Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA (1997) 2.73

Positional cloning: let's not call it reverse anymore. Nat Genet (1992) 2.69

Strategies for mapping and cloning macroregions of mammalian genomes. Methods Enzymol (1987) 2.68

Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucleic Acids Res (1990) 2.62

A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci U S A (2001) 2.57

Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA (1993) 2.51

Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet (1995) 2.42

Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci U S A (1998) 2.39

Molecular evolution of the psi eta-globin gene locus: gibbon phylogeny and the hominoid slowdown. Mol Biol Evol (1991) 2.33

A point mutation in the A gamma-globin gene promoter in Greek hereditary persistence of fetal haemoglobin. Nature (1985) 2.33

Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood (1995) 2.23

Globins: a case study in molecular phylogeny. Cold Spring Harb Symp Quant Biol (1987) 2.23

Strategies for mutational analysis of the large multiexon ATM gene using high-density oligonucleotide arrays. Genome Res (1998) 2.17

Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell (1997) 2.13

Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet (1993) 2.10

Mutational analysis using oligonucleotide microarrays. J Med Genet (1999) 2.05

cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics (1991) 2.03

Substrate nucleotide-determined non-templated addition of adenine by Taq DNA polymerase: implications for PCR-based genotyping and cloning. Biotechniques (1996) 2.02

History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology (2009) 2.01

MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Nat Genet (2000) 2.00

BRCA1--lots of mutations, lots of dilemmas. N Engl J Med (1996) 1.94

Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91

Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet (1997) 1.90

Evolutionary sequence comparisons using high-density oligonucleotide arrays. Nat Genet (1998) 1.90

Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization. J Clin Invest (1994) 1.86

Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell (1996) 1.84

G gamma beta+ hereditary persistence of fetal hemoglobin: cosmid cloning and identification of a specific mutation 5' to the G gamma gene. Proc Natl Acad Sci U S A (1984) 1.84

Fine-structure genetic mapping of human chromosomes using the polymerase chain reaction on single sperm: experimental design considerations. Am J Hum Genet (1989) 1.83

Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet (1998) 1.83

Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res (1997) 1.82

A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res (1997) 1.82

Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med (1998) 1.81

Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology (1993) 1.79

Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet (1997) 1.77

Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. Nat Genet (1997) 1.76

Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered (1999) 1.76

Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat Genet (1995) 1.75

Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA (1998) 1.73

Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem (1999) 1.73

Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR. Hum Mol Genet (1993) 1.71

Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet (1997) 1.70

Methods for precise sizing, automated binning of alleles, and reduction of error rates in large-scale genotyping using fluorescently labeled dinucleotide markers. FUSION (Finland-U.S. Investigation of NIDDM Genetics) Study Group. Genome Res (1997) 1.70

The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene (2001) 1.69

Distribution and lateral mobility of voltage-dependent sodium channels in neurons. J Cell Biol (1988) 1.68

Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol (2001) 1.67

Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin. Mol Cell Biol (1988) 1.63

Primate evolution at the DNA level and a classification of hominoids. J Mol Evol (1990) 1.58

CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain. Am J Physiol (1997) 1.57

Genetics and molecular biology of Huntington's disease. Trends Neurosci (1995) 1.57

Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci U S A (1991) 1.55

Recent advances in understanding the pathogenesis of Huntington's disease. Trends Neurosci (1999) 1.53

Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J Neurosci (2001) 1.52

A molecular view of primate phylogeny and important systematic and evolutionary questions. Mol Biol Evol (1989) 1.50

How is the Human Genome Project doing, and what have we learned so far? Proc Natl Acad Sci U S A (1995) 1.50

Direct construction of a chromosome-specific NotI linking library from flow-sorted chromosomes. Nucleic Acids Res (1989) 1.49

Duplication of the gamma-globin gene mediated by L1 long interspersed repetitive elements in an early ancestor of simian primates. Proc Natl Acad Sci U S A (1991) 1.48

Sequence analysis of the complete cDNA and encoded polypeptide for the Glued gene of Drosophila melanogaster. Proc Natl Acad Sci U S A (1987) 1.46

Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis (2001) 1.46

Magnetic bead capture of expressed sequences encoded within large genomic segments. Nature (1993) 1.45